[Oral administration of nicotinic acid hydrazide associated with glutamic acid in the treatment of tuberculous meningitis in children: possibility of increase of passage of the drug into the cerebrospinal fluid].
D000284:Administration, Oral; D001812:Blood-Brain Barrier / Q000502:physiology*; D002648:Child; D005971:Glutamates / Q000627:therapeutic use*; D018698:Glutamic Acid; D006801:Humans; D006834:Hydrazines; D007223:Infant; D009525:Niacin; D009539:Nicotinic Acids / Q000627:therapeutic use*; D014376:Tuberculosis; D014390:Tuberculosis, Meningeal
D005971:Glutamates; D006834:Hydrazines; D009539:Nicotinic Acids; D009525:Niacin; D018698:Glutamic Acid; C028571:nicotinic acid hydrazide
GLUTAMATES/therapeutic use; HEMATO-ENCEPHALIC BARRIER/physiology; NICOTINIC ACID ISOMERS/therapeutic use; TUBERCULOSIS, MENINGEAL/in infant and child
La somministrazione orale dell'idrazide dell'acido isonicotinico associata all'acido glutammico nel trattamento della meningite tubercolare infantile: possibilità di aumentare il passaggio nel liquor del farmaco.